Kati Kaijasilta

Kati Kaijasilta is a seasoned professional in the pharmaceutical industry with significant experience at Orion Corporation since November 1996. Currently serving as Business Development Director, Kati focuses on exploring collaboration opportunities in the Central Nervous System (CNS) and rare diseases sectors. Previous roles include temporary Director of CNS Business, where Kati managed an inspiring portfolio of treatments for neurodegenerative disorders, and Business Development Director, overseeing licensing projects and strategic partnerships for proprietary products. Kati's career began in clinical development, progressing through various roles in clinical research and project management. Additionally, Kati contributes as a Life Science Mentor at the Nordic Mentor Network for Entrepreneurship. Educational qualifications include an MBA from Henley Business School and an M.Sc. in Pharmacy from the University of Helsinki.